Home › Funds › Venrock Adviser, LLC › JBIO

Venrock Adviser, LLC position in JBIO

JADE BIOSCIENCES INC · Health Care

Venrock Adviser, LLC reported holding 3,220,364 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$71.6M, representing 2.17% of its reported portfolio and ranking #9 among its reported holdings. Venrock Adviser, LLC has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)3.22M sh
Reported value held$71.56M
Portfolio Weight2.17%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's JBIO position evolved

Venrock Adviser, LLC first disclosed a stake in JBIO in Q2 2025 at 3,220,364 shares (US$32.2M). The position peaked in Q2 2026 at 3,220,364 shares, worth US$71.6M. Across 5 filings, Venrock Adviser, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,220,364 shares valued at US$71.6M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 3.22M $32.17M New
Q3 2025 3.22M $27.79M Hold
Q4 2025 3.22M $49.69M Hold
Q1 2026 3.22M $45.25M Hold
Q2 2026 3.22M $71.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Bellevue Group AG (US$67.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Venrock Adviser, LLC held JBIO?

Venrock Adviser, LLC has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Venrock Adviser, LLC's current position in JBIO?

As of Q2 2026, Venrock Adviser, LLC holds 3.22M shares of JBIO (JADE BIOSCIENCES INC), valued at $71.56M, representing 2.17% of its reported portfolio and ranking #9.

Has Venrock Adviser, LLC been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in JBIO. The position peaked in Q2 2026 at 3.22M shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Bellevue Group AG, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.